265 related articles for article (PubMed ID: 29079454)
41. Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.
Ramirez CM; Lopez AM; Le LQ; Posey KS; Weinberg AG; Turley SD
Biochim Biophys Acta; 2014 Jan; 1841(1):54-61. PubMed ID: 24076310
[TBL] [Abstract][Full Text] [Related]
42. Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1.
Cougnoux A; Yerger JC; Fellmeth M; Serra-Vinardell J; Navid F; Wassif CA; Cawley NX; Porter FD
Mol Genet Metab; 2021 Dec; 134(4):330-336. PubMed ID: 34802899
[TBL] [Abstract][Full Text] [Related]
43. Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.
Lopez AM; Terpack SJ; Posey KS; Liu B; Ramirez CM; Turley SD
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):780-7. PubMed ID: 25115571
[TBL] [Abstract][Full Text] [Related]
44. Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder.
Lopez ME; Klein AD; Dimbil UJ; Scott MP
J Neurosci; 2011 Mar; 31(12):4367-78. PubMed ID: 21430138
[TBL] [Abstract][Full Text] [Related]
45. Main Olfactory and Vomeronasal Epithelium Are Differently Affected in Niemann-Pick Disease Type C1.
Witt M; Thiemer R; Meyer A; Schmitt O; Wree A
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424529
[TBL] [Abstract][Full Text] [Related]
46. Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration.
Liao G; Wang Z; Lee E; Moreno S; Abuelnasr O; Baudry M; Bi X
Exp Neurol; 2015 Jul; 269():67-74. PubMed ID: 25864931
[TBL] [Abstract][Full Text] [Related]
47. Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice.
Williams IM; Wallom KL; Smith DA; Al Eisa N; Smith C; Platt FM
Neurobiol Dis; 2014 Jul; 67():9-17. PubMed ID: 24631719
[TBL] [Abstract][Full Text] [Related]
48. Morphological alterations of the cornea in the mouse model of niemann-pick disease type c1.
Hovakimyan M; Stachs O; Reichard M; Mascher H; Lukas J; Frech MJ; Guthoff R; Witt M; Rolfs A; Wree A
Cornea; 2011 Jul; 30(7):796-803. PubMed ID: 21317782
[TBL] [Abstract][Full Text] [Related]
49. The adenosine A
Amodeo DA; Cuevas L; Dunn JT; Sweeney JA; Ragozzino ME
Autism Res; 2018 Feb; 11(2):223-233. PubMed ID: 29193861
[TBL] [Abstract][Full Text] [Related]
50. Visual evoked potentials of Niemann-Pick type C1 mice reveal an impairment of the visual pathway that is rescued by 2-hydroxypropyl-ß-cyclodextrin.
Palladino G; Loizzo S; Fortuna A; Canterini S; Palombi F; Erickson RP; Mangia F; Fiorenza MT
Orphanet J Rare Dis; 2015 Oct; 10():133. PubMed ID: 26458950
[TBL] [Abstract][Full Text] [Related]
51. Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin.
Maulik M; Ghoshal B; Kim J; Wang Y; Yang J; Westaway D; Kar S
Hum Mol Genet; 2012 Nov; 21(22):4857-75. PubMed ID: 22869680
[TBL] [Abstract][Full Text] [Related]
52. Alteration of GABAergic Input Precedes Neurodegeneration of Cerebellar Purkinje Cells of NPC1-Deficient Mice.
Rabenstein M; Murr N; Hermann A; Rolfs A; Frech MJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847086
[TBL] [Abstract][Full Text] [Related]
53. Donepezil enhances Purkinje cell survival and alleviates motor dysfunction by inhibiting cholesterol synthesis in a murine model of Niemann Pick disease type C.
Seo Y; Shin Y; Kim HS; Kang I; Hong IS; Choi SW; Yu KR; Kang KS
J Neuropathol Exp Neurol; 2014 Mar; 73(3):234-43. PubMed ID: 24487798
[TBL] [Abstract][Full Text] [Related]
54. Adenosine A
Zhao ZA; Zhao Y; Ning YL; Yang N; Peng Y; Li P; Chen XY; Liu D; Wang H; Chen X; Bai W; Chen JF; Zhou YG
Transl Psychiatry; 2017 May; 7(5):e1123. PubMed ID: 28485728
[TBL] [Abstract][Full Text] [Related]
55. NPC1 deficiency impairs cerebellar postnatal development of microglia and climbing fiber refinement in a mouse model of Niemann-Pick disease type C.
Boyle BR; Melli SE; Altreche RS; Padron ZM; Yousufzai FAK; Kim S; Vasquez MD; Carone DM; Carone BR; Soto I
Development; 2020 Aug; 147(21):. PubMed ID: 32611604
[TBL] [Abstract][Full Text] [Related]
56. Glutamatergic neurotransmission in a mouse model of Niemann-Pick type C disease.
D'Arcangelo G; Grossi D; De Chiara G; de Stefano MC; Cortese G; Citro G; Rufini S; Tancredi V; Merlo D; Frank C
Brain Res; 2011 Jun; 1396():11-9. PubMed ID: 21575932
[TBL] [Abstract][Full Text] [Related]
57. Increased interactions and engulfment of dendrites by microglia precede Purkinje cell degeneration in a mouse model of Niemann Pick Type-C.
Kavetsky L; Green KK; Boyle BR; Yousufzai FAK; Padron ZM; Melli SE; Kuhnel VL; Jackson HM; Blanco RE; Howell GR; Soto I
Sci Rep; 2019 Oct; 9(1):14722. PubMed ID: 31605022
[TBL] [Abstract][Full Text] [Related]
58. Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for
Tseng WC; Loeb HE; Pei W; Tsai-Morris CH; Xu L; Cluzeau CV; Wassif CA; Feldman B; Burgess SM; Pavan WJ; Porter FD
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135069
[TBL] [Abstract][Full Text] [Related]
59. Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C.
Chu TT; Tu X; Yang K; Wu J; Repa JJ; Yan N
Nature; 2021 Aug; 596(7873):570-575. PubMed ID: 34290407
[TBL] [Abstract][Full Text] [Related]
60. In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C- associated liver disease.
Rimkunas VM; Graham MJ; Crooke RM; Liscum L
Hepatology; 2008 May; 47(5):1504-12. PubMed ID: 18438776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
